• Pterostilbene, Mitophagy, and Dermal Fibroblast Senescence

  2026-09-01

  Zhou et al. show that pterostilbene attenuates human dermal fibroblast senescence in both UVB-induced and replicative models while improving mitochondrial morphology, membrane potential, reactive oxygen species control, and respiration. The study’s central contribution is linking improved mitochondrial quality to enhanced mitophagy, with supporting evidence from a UVB-exposed mouse skin model.

• DiscoveryProbe Natural Product Library Plus

  2026-08-31

  Learn how DiscoveryProbe™ Natural Product Library Plus (Catalog No. L1039P; SKU L1039P) can support reproducible cell viability, proliferation, cytotoxicity, and mechanism-oriented screening. This scenario-driven guide connects library format, compound handling, assay controls, and published antiparasitic findings to practical laboratory decisions.

• PARP7, STAT1/2, and EAE: Mechanistic Insights

  2026-08-31

  Xu et al. show that PARP7 suppresses type I interferon signaling by ADP-ribosylating STAT1 and STAT2, promoting their ubiquitination and p62-dependent autophagic degradation. Pharmacological PARP7 inhibition restored interferon pathway activity and reduced experimental autoimmune encephalomyelitis in mice, providing a mechanistic framework for multiple sclerosis research.

• Tacrine hydrochloride hydrate: Assay Logic

  2026-08-30

  Tacrine hydrochloride hydrate and Tetrahydroaminacrine are examined here as mechanistic assay tools rather than simple benchmark inhibitors. This article connects cholinesterase pharmacology with metabolism-aware experimental design, helping researchers interpret enzyme, cellular, and neuroprotection data more rigorously.

• Apicidin: HDAC Inhibitor Mechanism and Evidence

  2026-08-29

  Apicidin is a fungal histone deacetylase inhibitor with reported activity against HDAC3 and HDAC6. Evidence supports anti-proliferative, anti-angiogenesis, antiparasitic, tumor growth suppression, and reproductive-toxicology research applications, but the compound remains a research reagent rather than a medical treatment.

• Palbociclib Beyond Cell-Cycle Arrest

  2026-08-29

  Palbociclib (PD0332991) Isethionate is more than a selective CDK4/6 inhibitor: it is a translational probe for testing how Rb-dependent cell-cycle control behaves in patient-derived tumor ecosystems. By pairing mechanistic assays with gastric cancer assembloids, researchers can distinguish intrinsic drug sensitivity from stromal protection and design more predictive breast cancer, RCC, and broader oncology workflows.

• LRRC8A–Caveolin-1 Axis in PDAC Growth

  2026-08-28

  The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 complex that links cell-volume regulation with KRAS/EGFR signaling, ribosome biogenesis, and pancreatic ductal adenocarcinoma growth. By combining genetic and pharmacological perturbation with xenografts and patient-derived organoids, the work provides a mechanistic framework for studying how membrane organization supports biosynthetic expansion.

• CFTRinh-172: A Functional Lens on CFTR Trafficking

  2026-08-28

  CFTRinh-172 is a selective CFTR inhibitor for separating channel activity from plasma-membrane abundance. This article develops a paired assay strategy that connects acute chloride transport blockade with new findings on SHC-1-dependent CFTR trafficking.

• CIAV Exploits CK2α Through VP2 to Drive Replication

  2026-08-27

  Ma et al. identify host CK2α as an essential cellular factor that binds CIAV VP2, protects it from proteasomal degradation, and supports viral replication. Mutating VP2 Ser182 and Asp183 disrupted this interaction, reduced replication, and attenuated virus-associated bone marrow and thymic injury, defining a mechanistic host–virus interface with potential antiviral relevance.

• Carbenoxolone disodium: Practical Lab Guide

  2026-08-27

  Carbenoxolone disodium is a research reagent for perturbing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell- and tissue-based workflows. It is best used for controlled mechanistic studies, not as a selective in vivo efficacy treatment or a stand-alone proof of target specificity.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-26

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin reagent for visualizing accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cell or tissue samples. It is intended for carbohydrate-focused immunofluorescence and flow cytometry workflows, not for identifying non-carbohydrate targets or measuring a specific glycoprotein without an additional assay.

• Fluorescein Tyramide for Rare-Target Neuroscience

  2026-08-26

  Fluorescein Tyramide offers a practical route to high-sensitivity detection when low-abundance oxytocin pathway markers are difficult to resolve. This article translates a recent early-life adversity study into assay-design decisions for IHC, ISH, and flow cytometry.

• Sisomicin: Designing Better Antibacterial Assays

  2026-08-25

  Sisomicin is an aminoglycoside antibiotic whose measured activity depends strongly on isolate selection, inoculum, medium, and endpoint definition. This assay-centered guide interprets the landmark clinical-isolate study and translates its lessons into more reproducible antibacterial research decisions.

• CpAdhE Inhibition by Antifungal Imidazoles

  2026-08-25

  Chen et al. characterized the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a metabolic vulnerability in Cryptosporidium parvum and identified antifungal imidazoles as low-micromolar enzyme inhibitors. The study connects biochemical inhibition with parasite-growth suppression, providing a rational framework for target-based anti-cryptosporidial discovery while leaving questions about selectivity and in vivo efficacy open.

• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-08-24

  Build a rapid apoptosis readout into cytotoxicity, immunology, and live-cell workflows with minimal handling. The assay adds a critical cell-survival endpoint to inflammatory models such as LPS-stimulated monocytes, helping distinguish immune modulation from treatment-related cell loss.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page